Evolution of DNA Supply, What Advances in DNA Synthesis will Unlock the Agile Development of Biology.
Chris Ghadban, Principal of Alix Ventures, moderates a panel of guests including Matthew Hill, Founder and CEO of Elegen, Jacob Becraft, Co-Founder and CEO of Strand Therapeutics, Tim Lu, Co-founder and CEO of Senti Bio, Cristina Butterfield, Sr. Director of Biochemistry at Metagenomi, and Patrick Boyle, Organism Designer at Ginkgo Bioworks, to discuss how a better solution for DNA synthesis will enable synthetic biologists to realize the promise of programmable biology.
